Target intelligence / Profile preview

Human nucleic acids (DNA/RNA)

Target
DNA/RNA
Molecular classification
Nucleic acid, Biopolymer, Other
01

Overview

Human nucleic acids, comprising deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), serve as the fundamental repositories and transmitters of genetic information within the cell [National Human Genome Research Institute (NHGRI)]. DNA primarily functions in the long-term storage of genetic blueprints, while various forms of RNA, including mRNA, tRNA, and rRNA, facilitate the translation of these blueprints into functional proteins [Nature Education]. In the context of pharmacology, nucleic acids are targeted by a wide array of therapeutic agents; for instance, traditional chemotherapeutics like cisplatin cross-link DNA to induce apoptosis in rapidly dividing cancer cells [PubChem]. Modern therapeutic strategies have expanded to include antisense oligonucleotides and small interfering RNAs (siRNAs) that specifically modulate RNA stability or translation to treat genetic and metabolic disorders [Nature Reviews Drug Discovery]. Despite their central role in therapy, targeting nucleic acids poses significant challenges, including the risk of secondary malignancies due to genomic instability and the difficulty of achieving sequence-specific delivery [American Cancer Society].

Other names
Deoxyribonucleic acidRibonucleic acidGenomic DNACellular RNAGenetic materialPolynucleotide
02

Mechanism of action

Mechanisms include DNA alkylation, intercalation, strand cross-linking, antimetabolite incorporation, antisense inhibition, and RNA interference [Nature Reviews Drug Discovery, PubChem].

03

Biological functions

Genetic information storageProtein synthesisGene regulationHeredityCatalysisOther
04

Disease associations

CancerGenetic disorderAutoimmune diseaseInfectionOther
05

Safety considerations

GenotoxicityMutagenicitySecondary malignanciesMyelosuppressionOff-target RNA bindingInnate immune activation
06

Interacting drugs

Cisplatin

7 more in the full profile.

07

Biomarkers

Circulating tumor DNA (ctDNA)MicroRNA expression profilesDNA methylation statusMicrosatellite instability (MSI)Tumor mutational burden (TMB)

Beyond the preview

Go deeper on Human nucleic acids (DNA/RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human nucleic acids (DNA/RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call